STOCK TITAN

Curaleaf (OTCQX: CURLF) sells US$500M 11.5% senior secured notes due 2029

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Curaleaf Holdings has closed a private placement of US$500 million aggregate principal amount of 11.5% senior secured notes due February 18, 2029. The notes were issued at 100% of face value and are payable semi-annually until maturity, unless earlier redeemed or purchased.

The company redeemed its previously outstanding US$475 million senior secured notes due December 15, 2026, extending its debt maturity profile while raising additional capital. Curaleaf plans to use net proceeds to support global growth initiatives and to pay transaction fees and expenses, under an indenture that also permits additional note issuance and up to US$100 million of senior bank financing.

Positive

  • None.

Negative

  • None.

Insights

Curaleaf refinances debt with a large, higher-yield 2029 note.

Curaleaf completed a private placement of US$500 million in 11.5% senior secured notes due 2029, issued at par. Proceeds fund the redemption of US$475 million notes due 2026 and provide incremental capital for global growth plus transaction costs.

The transaction extends the company’s debt maturity from 2026 to 2029 and modestly increases gross debt, while locking in a relatively high fixed coupon of 11.5%. The indenture allows additional note issuance subject to leverage covenants and up to US$100 million of senior bank financing, so future filings will be important for tracking total leverage and capital deployment.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of February, 2026
Commission File Number: 333-249081
Curaleaf Holdings, Inc.
(Name of Registrant)
666 Burrard Street, Suite 1700,
Vancouver, British Columbia V6C 2X8, Canada
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐    Form 40-F ☒



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CURALEAF HOLDINGS, INC.
(Registrant)
Date:
February 20, 2026
By:
/s/ Peter Clateman
Name:
Peter Clateman
Title:
Chief Legal Officer



EXHIBIT INDEX

Exhibit Number
Description
99.1
Press Release

Curaleaf Holdings, Inc. Investor Relations CURALEAF ANNOUNCES CLOSING OF $500 MILLION PRIVATE PLACEMENT OF 11.5% SENIOR SECURED NOTES DUE 2029 STAMFORD, Conn., Feb. 19, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has closed the previously announced private placement (the "Offering") of US$500 million aggregate principal amount of 11.5% senior secured notes due February 18, 2029 (the "Notes") and the redemption of its previously outstanding US$475 million senior secured notes due December 15, 2026. The Company intends to use the net proceeds of the Offering to provide incremental capital to support global growth initiatives, and to pay transaction fees and expenses. The non-dilutive Notes, which were issued at 100% of face value, are senior secured obligations of the Company, payable semi-annually in equal installments until the maturity date, unless earlier redeemed or purchased. The Notes are governed by a trust indenture supplemented on closing of the Offering which permits additional note issuances subject to leverage covenants and other terms and conditions, as well as up to US$100 million of senior bank financing. "The successful closing of this landmark private placement delivers a powerful endorsement of Curaleaf's strategy and long- term vision. I am exceptionally proud of our team for delivering the largest bond offering completed in the cannabis sector – broadening the universe of institutional investors and reinforcing Curaleaf's leadership position in the industry," said Boris Jordan, Chairman and CEO of Curaleaf. "With an extended runway into 2029 and enhanced capital flexibility, we are well positioned to accelerate our global expansion and capture key strategic opportunities across the international cannabis market. The renewed institutional demand we are seeing marks a pivotal inflection point for the sector and signals the emergence of a new era of confidence, credibility, and long-term growth for the global cannabis industry." The Notes were offered on a private placement basis in certain provinces and territories of Canada pursuant to applicable exemptions from the prospectus requirements of Canadian securities laws. The Notes were also sold in the United States to or for the account or benefit of "U.S. persons" (as defined in the United States Securities Act of 1933, as amended (the "U.S. Securities Act")), on a private placement basis to "qualified institutional buyers" and "accredited investors" pursuant to an exemption from the registration requirements of the U.S. Securities Act. The Notes issued are subject to a customary four- month hold period under Canadian securities laws. Seaport Global Securities, LLC acted as lead placement agent and ATB Cormark Capital Markets (the "Agents") was co- placement agent for the Notes in the United States and Canada, respectively. No securities regulatory authority has either approved or disapproved of the contents of this news release. The Notes have not been and will not be registered under the U.S. Securities Act or any state securities laws. Accordingly, the Notes were not offered or sold within the United States or to or for the account or benefit of "U.S. persons" unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com. Curaleaf IR Twitter Account: https://twitter.com/Curaleaf_IR Investor Relations Website: https://ir.curaleaf.com/ Forward Looking Statements This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be


 
identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the intended use of the net proceeds from the Offering. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR+ profile at http://www.sedarplus.ca, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release. Investor Contact: Curaleaf Holdings, Inc. Camilo Lyon, Chief Investment Officer IR@curaleaf.com Media Contact: MATTIO Communications MattioCuraleaf@Mattio.com SOURCE Curaleaf Holdings, Inc. https://ir.curaleaf.com/2026-02-19-CURALEAF-ANNOUNCES-CLOSING-OF-500-MILLION-PRIVATE-PLACEMENT-OF-11-5- SENIOR-SECURED-NOTES-DUE-2029


 

FAQ

What financing transaction did Curaleaf Holdings (CURLF) complete in February 2026?

Curaleaf completed a private placement of US$500 million 11.5% senior secured notes due February 18, 2029. The notes were issued at 100% of face value and provide capital to refinance existing debt and support the company’s global growth initiatives and related transaction costs.

What are the key terms of Curaleaf Holdings’ new 11.5% senior secured notes?

The new Curaleaf notes total US$500 million in aggregate principal amount, carry an 11.5% coupon, and mature on February 18, 2029. Interest is payable semi-annually in equal installments, and the notes are senior secured obligations that may be redeemed or purchased before maturity under applicable terms.

How is Curaleaf Holdings (CURLF) using the proceeds from its US$500 million note offering?

Curaleaf intends to use the net proceeds from the US$500 million offering to redeem its previously outstanding US$475 million senior secured notes due December 15, 2026, provide incremental capital to support global growth initiatives, and cover associated transaction fees and expenses detailed in the announcement.

What existing debt did Curaleaf refinance with the new senior secured notes?

Curaleaf redeemed its previously outstanding US$475 million senior secured notes due December 15, 2026 using proceeds from the new US$500 million notes. This refinancing extends the company’s debt maturity profile from 2026 to 2029 while also raising additional capital for strategic initiatives and costs.

Where and to whom did Curaleaf offer its US$500 million senior secured notes?

Curaleaf offered the notes on a private placement basis in certain Canadian provinces and territories under prospectus exemptions, and in the United States to or for the account or benefit of U.S. persons who are qualified institutional buyers or accredited investors, relying on exemptions from U.S. Securities Act registration requirements.

Do Curaleaf’s new 11.5% senior secured notes involve potential additional financing capacity?

Yes. The trust indenture governing Curaleaf’s US$500 million notes permits additional note issuances subject to leverage covenants and other conditions. It also allows up to US$100 million of senior bank financing, creating further potential borrowing capacity within the capital structure if future conditions and covenants permit.

Filing Exhibits & Attachments

1 document
Curaleaf Hldgs

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Latest SEC Filings

CURLF Stock Data

1.94B
616.07M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Stamford